AbbVie Inc - Operating Return On Assets
AbbVie Inc's Fiscal Year is From January To December - All Figures are in Percent.
The item "Operating-Return-On-Assets" stands at 9.58 percent as of 09/30/2025.
As of the end of AbbVie Inc's third quarter, the item "Operating Return On Assets" stands at 9.58 Percent. This represents an increase of 0.93 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.1337 percentage points compared to the value the year prior.
The 1 year change in percentage points is -0.1337.
The 3 year change in percentage points is -2.74.
The Serie's change in percentage points from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +3.17.
The Serie's change in percentage points from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -3.21.
Operating Return On Assets for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Operating Return On Assets | 905,699,262,464.00 |
 | Johnson & Johnson - Operating Return On Assets | 486,508,953,600.00 |
 | Roche Holding AG - Operating Return On Assets | 317,433,206,677.55 |
 | AstraZeneca PLC - Operating Return On Assets | 280,205,508,085.11 |
 | Novartis AG - Operating Return On Assets | 255,096,620,580.91 |